These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23710793)

  • 21. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
    Alberts DS; Dorr RT
    Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of anthracycline extravasation injuries.
    Reeves D
    Ann Pharmacother; 2007 Jul; 41(7):1238-42. PubMed ID: 17550954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extravasation: a dreaded complication of chemotherapy.
    Schrijvers DL
    Ann Oncol; 2003; 14 Suppl 3():iii26-30. PubMed ID: 12821535
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion.
    Comas D; Mateu J
    Ann Pharmacother; 1996 Mar; 30(3):244-6. PubMed ID: 8833558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin.
    Olver IN; Schwarz MA
    Cancer Treat Rep; 1983 Apr; 67(4):407-8. PubMed ID: 6850659
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of dimethyl sulfoxide and local cooling as antidotes for doxorubicin extravasation in a pig model.
    Harwood KV; Bachur N
    Oncol Nurs Forum; 1987; 14(1):39-44. PubMed ID: 3643588
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats.
    Marshall RF; Arthaud LE; MacDonald JR
    Cancer Chemother Pharmacol; 2000; 45(5):397-401. PubMed ID: 10803923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity to topical dimethyl sulfoxide (DMSO) when used as an extravasation antidote.
    Creus N; Mateu J; Massó J; Codina C; Ribas J
    Pharm World Sci; 2002 Oct; 24(5):175-6. PubMed ID: 12426960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against adriamycin-induced skin necrosis in the rat by dimethyl sulfoxide and alpha-tocopherol.
    Svingen BA; Powis G; Appel PL; Scott M
    Cancer Res; 1981 Sep; 41(9 Pt 1):3395-9. PubMed ID: 7260905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DMSO and extravasation of mitomycin.
    Herrera D; Burnham N
    Oncol Nurs Forum; 1989; 16(2):155. PubMed ID: 2928263
    [No Abstract]   [Full Text] [Related]  

  • 33. Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide.
    Dorr RT; Soble MJ; Liddil JD; Keller JH
    J Clin Oncol; 1986 Sep; 4(9):1399-404. PubMed ID: 3091779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia.
    Lopez AM; Wallace L; Dorr RT; Koff M; Hersh EM; Alberts DS
    Cancer Chemother Pharmacol; 1999; 44(4):303-6. PubMed ID: 10447577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An experimental investigation on preventive measures of skin ulcers induced by extravascular mitomycin C].
    Wang GH; Chen M; Zhang XQ
    Zhonghua Hu Li Za Zhi; 1995 Feb; 30(2):67-70. PubMed ID: 7664374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
    Frost A; Gmehling D; Azemar M; Unger C; Mross K
    Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte macrophage-colony stimulating factor for treatment of chemotherapy extravasation.
    Shamseddine AI; Khalil AM; Kibbi AG; Abu Nasr TA; Seoud MA; El Saghir NS
    Eur J Gynaecol Oncol; 1998; 19(5):479-81. PubMed ID: 9863917
    [No Abstract]   [Full Text] [Related]  

  • 39. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations.
    St Germain B; Houlihan N; D'Amato S
    J Intraven Nurs; 1994; 17(5):261-6. PubMed ID: 7965372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of chitosan and hyaluronidase on skin damage caused by docetaxel extravasation in rats].
    Zhu QC; Li AM; Luo RC; Liang WJ; Dai M; Chen XH
    Ai Zheng; 2007 Apr; 26(4):346-50. PubMed ID: 17430649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.